SlideShare a Scribd company logo
2
Most read
3
Most read
6
Most read
1
Form B (per rule 8(a)* for Submission of Research Protocol (s)
Application for Permission for Animal Experiments
Application to be submitted to the CPCSEA, New Delhi after approval of Institutional
Animal Ethics Committee (IAEC)
Section -I
1. Name and address of establishment
2.
Registration number and date of
registration.
3.
Name, address and registration number
of breeder from which animals
acquired (or to be acquired) for
experiments mentioned in parts B & C
4.
Place where the animals are presently
kept (or proposed to be kept).
5.
Place where the experiment is to be
performed (Please provide CPCSEA
Reg. Number)
6. Date and Duration of experiment.
7.
Type of research involved (Basic
Research / Educational/ Regulatory/
Contract Research)
Signature
Name and Designation of Investigator
Date:
Place:
2
Section -II
Protocol form for research proposals to be submitted to the Institutional Animal
Ethics Committee/ CPCSEA, for new experiments or extensions of ongoing
experiments using animals.
1. Project / Dissertation / Thesis Title:
2. Principal Investigator / Research Guide / Advisor:
a. Name
b. Designation
c. Dept / Div/ Lab
d. Telephone No.
e. E-mail Id
f. Experience in Lab animal experimentation
3. List of all individuals authorized to conduct procedures under this proposal.
a. Name
b. Designation
c. Department
d. Telephone No.
e. E-mail Id
f. Experience in Lab animal experimentation
4. Funding Source / Proposed Funding Source with complete address (Please attach
the proof)
5. Duration of the animal experiment.
a. Date of initiation (Proposed)
b. Date of completion (Proposed)
6. Describe details of study plan to justify the use of animals (Enclose Annexure)
3
7. Animals required
a. Species and Strain
b. Age and Weight
c. Gender
d. Number to be used (Year-wise breakups and total figures needed tobe
given in tabular form)
e. Number of days each animal will be housed.
8. Rationale for animal usage
a. Why is animal usage necessary for these studies?
b. Whether similar study has been conducted on in vitro models? If yes,
describe the leading points to justify the requirement of animal
experiment.
c. Why are the particular species selected?
d. Why is the estimated number of animals essential?
e. Are similar experiments conducted in the past in your establishment?
f. If yes, justify why new experiment is required?
g. Have similar experiments been conducted by any other organization in
same or other in vivo models? If yes, enclose the reference.
9. Describe the procedures in detail:
a. Describe all invasive and potentially stressful non-invasive procedures that
animals will be subjected to in the course of the experiments)
b. Furnish details of injections schedule Substances:
Doses :
Sites :
Volumes :
c. Blood withdrawal Details:
Volumes :
Sites :
d. Radiation (dosage and schedules):
e. Nature of compound/Broad Classification of drug/NCE (the chemical
characteristic details of NCE and its likely reaction to the biological system and
characteristic details of invitro study of that NCE have to be submitted by the
establishment) :
10. Does the protocol prohibit use of anesthetic or analgesic for the conduct of
painful procedures? If yes, justify.
11. Will survival surgery be done?
4
If yes, the following to be described.
5
a. List and describe all surgical procedures (includingmethods of asepsis)
b. Names, qualifications and experience levels of personnels involved.
c. Describe post-operative care
d. Justify if major survival surgery is to be performed more thanonce on a
single animal.
12. Describe post-experimentation procedures.
a. Scope for Reuse :
b. Rehabilitation (Name and Address, where the animals are proposed to be
rehabilitated) :
c. Describe method of Euthanasia (If required in the protocol) :
d. Method of carcass disposal after euthanasia. :
13. Describe animal transportation methods if extra-institutional transport is
envisaged.
14. Use of hazardous agents (use of recombinant DNA-based agents or potential
human pathogens requires documented approval of the Institutional Biosafety
Committee (IBC). For each category, the agents and the biosafety level required,
appropriate therapeutic measures and the mode of disposal of contaminated food,
animal wastes and carcasses must be identified).
If, your project involved use of any of the below mentioned agent, attach copy of
the approval certificates of the respective agencies:
(a) Radionucleotides (AERB)
(b) Microorganisms / Biological infectious Agents (IBSC)
(c) Recombinant DNA (RCGM)
(d) Any other Hazardous Chemical / Drugs
6
Investigator’s declaration.
1. I certify that the research proposal submitted is not unnecessarily
duplicative of previously reported research.
2. I certify that, I am qualified and have experience in the
experimentation on animals.
3. For procedures listed under item 10, I certify that I have reviewed
the pertinent scientific literature and have found no valid alternative
to any procedure described herein which may cause less pain or
distress.
4. I will obtain approval from the IAEC/ CPCSEA before initiating
any changes in this study.
5. I certify that performance of experiment will be initiated only upon
review and approval of scientific intent by appropriate expert body
(Institutional Scientific Advisory Committee / funding agency /
other body).
6. I certify that I will submit appropriate certification of review and
concurrence for studies mentioned in point 14.
7. I shall maintain all the records as per format (Form D) and submit to
Institutional Animal Ethics Committee (IAEC).
8. I certify that, I will not initiate the study before approval from
IAEC/ CPCSEA received in writing. Further, I certify that I will
follow the recommendations of IAEC/ CPCSEA.
9. I certify that I will ensure the rehabilitation policies are adopted
(wherever required).
Signature
Name ofInvestigator
Date:
7
Certificate
This is to certify that the project proposal no ........................................entitled
……………………… submitted by Dr./ Mr. / Ms. ………………………………..
has been approved/recommended by the IAEC of……………(Organization) in its
meeting held on…………. (date) and ………………(Number and Species of animals)
have been sanctioned under this proposal for a duration of next ……………………..
months.
Authorized by Name Signature Date
Chairman: ……………………. ……………… ………………..
Member Secretary: ……………………. ……………… ………………..
Main Nominee of
CPCSEA:
……………………. ……………… ………………..
(Kindly make sure that minutes of the meeting duly signed by all the
participants are maintained by Office)

More Related Content

PPTX
Skin sensitisation (OECD: 406).
PPTX
CPCSEA guidelines ppt
PPTX
Schedule y
PPTX
Cpcsea guidelines
PPTX
Schedule Y Regulation For Animal Toxicity Studies
PPTX
Antidiabetic screening
PPTX
Inhalation Toxicity Studies- OECD guidelines
PPTX
Acute eye irritation oecd
Skin sensitisation (OECD: 406).
CPCSEA guidelines ppt
Schedule y
Cpcsea guidelines
Schedule Y Regulation For Animal Toxicity Studies
Antidiabetic screening
Inhalation Toxicity Studies- OECD guidelines
Acute eye irritation oecd

What's hot (20)

PPTX
CPCSEA GUIDELINE
PPTX
PPTX
Acute dermal irritation/corrosion: OECD 404
PPTX
SCREENING OF ANTI CANCER DRUGS
PPTX
screening methodes of anti-diabetic drugs
PPTX
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
PPTX
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
PPTX
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
PDF
Ind enabling studies.
PPTX
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
PPTX
Investigational New Drug Application enabling studies.pptx
PPTX
Screening of Dyslipidemic drugs
PPTX
screening of antiulcer agents
DOCX
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
PPTX
Detection and Reporting of Adverse Reaction
PPTX
WHO international drug monitoring programme.pptx
PPTX
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
PPTX
Preclinical Screening of Antiasthmatic Drugs
PPTX
pre clinical Screening for anti asthmatic drugs
CPCSEA GUIDELINE
Acute dermal irritation/corrosion: OECD 404
SCREENING OF ANTI CANCER DRUGS
screening methodes of anti-diabetic drugs
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
Ind enabling studies.
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Investigational New Drug Application enabling studies.pptx
Screening of Dyslipidemic drugs
screening of antiulcer agents
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
Detection and Reporting of Adverse Reaction
WHO international drug monitoring programme.pptx
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Preclinical Screening of Antiasthmatic Drugs
pre clinical Screening for anti asthmatic drugs
Ad

Similar to Form B (per rule 8(a)*for Submission of Research Protocol (20)

PPTX
Presentation of Regulatory bodies of the Indian atmosphere
PDF
CPCSEA Guidelines Dr Santosh B Dighe.pdf
PPTX
CPCSEA Guidelines
PPTX
Cpcsea presentation
PPTX
CPCSEA GUIDELINE .pptx
PPTX
CPCSEA and IAEC guidelines for animal safety and experiment. it is a regulato...
PPTX
CPCSEA- Guidelines
PPTX
CPCSEA.pptx
PPTX
Committee for the purpose of control and supervision of experiments on animal...
PPTX
CPCSEA Guidelines
PPTX
Animal laboratory care and ethical requirements
PPT
PPTX
CCSEA guidelines of experiment on animals.pptx
PPTX
CCSEA -VALIANT.pptx
PDF
2015 IACUC Protocol for GLP Animal Study
PPTX
Cpcsea guidelines
PPT
CPCSEA Guidelines
PDF
cpcsea-180516143428 (2).pdf
PPT
CPCSEA ppt final (S S C)
Presentation of Regulatory bodies of the Indian atmosphere
CPCSEA Guidelines Dr Santosh B Dighe.pdf
CPCSEA Guidelines
Cpcsea presentation
CPCSEA GUIDELINE .pptx
CPCSEA and IAEC guidelines for animal safety and experiment. it is a regulato...
CPCSEA- Guidelines
CPCSEA.pptx
Committee for the purpose of control and supervision of experiments on animal...
CPCSEA Guidelines
Animal laboratory care and ethical requirements
CCSEA guidelines of experiment on animals.pptx
CCSEA -VALIANT.pptx
2015 IACUC Protocol for GLP Animal Study
Cpcsea guidelines
CPCSEA Guidelines
cpcsea-180516143428 (2).pdf
CPCSEA ppt final (S S C)
Ad

More from Drx.Urvashi Saini (11)

PPTX
Biotransformation or metabolism of Drugs Unit-4.pptx.
PPTX
Non linear pharmacokinetics Unit-4.pptx.
DOCX
Overview on History of computers in pharmaceutical research an.docx
PPTX
Medical Research Unit 5 Research Methodology.ppt
PDF
Story Board on the Evolution of Tablet in Pharmacy.
PDF
Do and Don't For performing Animal Experiments.
PDF
Story Board on Novel Drug Delivery System.pdf
PPTX
Formulation and Evaluation of Microsoheres .pptx
PPTX
ACNE VULGARIS SlideShare M410-1.pptx
PPTX
Pharmaceutical Automation,Computer aided drug development.pptx
PDF
Story Board on History of Computers in Pharmacy.pdf
Biotransformation or metabolism of Drugs Unit-4.pptx.
Non linear pharmacokinetics Unit-4.pptx.
Overview on History of computers in pharmaceutical research an.docx
Medical Research Unit 5 Research Methodology.ppt
Story Board on the Evolution of Tablet in Pharmacy.
Do and Don't For performing Animal Experiments.
Story Board on Novel Drug Delivery System.pdf
Formulation and Evaluation of Microsoheres .pptx
ACNE VULGARIS SlideShare M410-1.pptx
Pharmaceutical Automation,Computer aided drug development.pptx
Story Board on History of Computers in Pharmacy.pdf

Recently uploaded (20)

PPTX
UV-Visible spectroscopy..pptx UV-Visible Spectroscopy – Electronic Transition...
PDF
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
PPTX
Orientation - ARALprogram of Deped to the Parents.pptx
PDF
Yogi Goddess Pres Conference Studio Updates
PDF
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PPTX
Microbial diseases, their pathogenesis and prophylaxis
PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PPTX
Introduction-to-Literarature-and-Literary-Studies-week-Prelim-coverage.pptx
PDF
Paper A Mock Exam 9_ Attempt review.pdf.
PPTX
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE
DOC
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
PDF
LNK 2025 (2).pdf MWEHEHEHEHEHEHEHEHEHEHE
PDF
Practical Manual AGRO-233 Principles and Practices of Natural Farming
PDF
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
PDF
Weekly quiz Compilation Jan -July 25.pdf
PDF
RMMM.pdf make it easy to upload and study
PDF
A systematic review of self-coping strategies used by university students to ...
PPTX
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
PDF
Trump Administration's workforce development strategy
UV-Visible spectroscopy..pptx UV-Visible Spectroscopy – Electronic Transition...
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
Orientation - ARALprogram of Deped to the Parents.pptx
Yogi Goddess Pres Conference Studio Updates
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
STATICS OF THE RIGID BODIES Hibbelers.pdf
Microbial diseases, their pathogenesis and prophylaxis
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
Introduction-to-Literarature-and-Literary-Studies-week-Prelim-coverage.pptx
Paper A Mock Exam 9_ Attempt review.pdf.
Tissue processing ( HISTOPATHOLOGICAL TECHNIQUE
Soft-furnishing-By-Architect-A.F.M.Mohiuddin-Akhand.doc
LNK 2025 (2).pdf MWEHEHEHEHEHEHEHEHEHEHE
Practical Manual AGRO-233 Principles and Practices of Natural Farming
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
Weekly quiz Compilation Jan -July 25.pdf
RMMM.pdf make it easy to upload and study
A systematic review of self-coping strategies used by university students to ...
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
Trump Administration's workforce development strategy

Form B (per rule 8(a)*for Submission of Research Protocol

  • 1. 1 Form B (per rule 8(a)* for Submission of Research Protocol (s) Application for Permission for Animal Experiments Application to be submitted to the CPCSEA, New Delhi after approval of Institutional Animal Ethics Committee (IAEC) Section -I 1. Name and address of establishment 2. Registration number and date of registration. 3. Name, address and registration number of breeder from which animals acquired (or to be acquired) for experiments mentioned in parts B & C 4. Place where the animals are presently kept (or proposed to be kept). 5. Place where the experiment is to be performed (Please provide CPCSEA Reg. Number) 6. Date and Duration of experiment. 7. Type of research involved (Basic Research / Educational/ Regulatory/ Contract Research) Signature Name and Designation of Investigator Date: Place:
  • 2. 2 Section -II Protocol form for research proposals to be submitted to the Institutional Animal Ethics Committee/ CPCSEA, for new experiments or extensions of ongoing experiments using animals. 1. Project / Dissertation / Thesis Title: 2. Principal Investigator / Research Guide / Advisor: a. Name b. Designation c. Dept / Div/ Lab d. Telephone No. e. E-mail Id f. Experience in Lab animal experimentation 3. List of all individuals authorized to conduct procedures under this proposal. a. Name b. Designation c. Department d. Telephone No. e. E-mail Id f. Experience in Lab animal experimentation 4. Funding Source / Proposed Funding Source with complete address (Please attach the proof) 5. Duration of the animal experiment. a. Date of initiation (Proposed) b. Date of completion (Proposed) 6. Describe details of study plan to justify the use of animals (Enclose Annexure)
  • 3. 3 7. Animals required a. Species and Strain b. Age and Weight c. Gender d. Number to be used (Year-wise breakups and total figures needed tobe given in tabular form) e. Number of days each animal will be housed. 8. Rationale for animal usage a. Why is animal usage necessary for these studies? b. Whether similar study has been conducted on in vitro models? If yes, describe the leading points to justify the requirement of animal experiment. c. Why are the particular species selected? d. Why is the estimated number of animals essential? e. Are similar experiments conducted in the past in your establishment? f. If yes, justify why new experiment is required? g. Have similar experiments been conducted by any other organization in same or other in vivo models? If yes, enclose the reference. 9. Describe the procedures in detail: a. Describe all invasive and potentially stressful non-invasive procedures that animals will be subjected to in the course of the experiments) b. Furnish details of injections schedule Substances: Doses : Sites : Volumes : c. Blood withdrawal Details: Volumes : Sites : d. Radiation (dosage and schedules): e. Nature of compound/Broad Classification of drug/NCE (the chemical characteristic details of NCE and its likely reaction to the biological system and characteristic details of invitro study of that NCE have to be submitted by the establishment) : 10. Does the protocol prohibit use of anesthetic or analgesic for the conduct of painful procedures? If yes, justify. 11. Will survival surgery be done?
  • 4. 4 If yes, the following to be described.
  • 5. 5 a. List and describe all surgical procedures (includingmethods of asepsis) b. Names, qualifications and experience levels of personnels involved. c. Describe post-operative care d. Justify if major survival surgery is to be performed more thanonce on a single animal. 12. Describe post-experimentation procedures. a. Scope for Reuse : b. Rehabilitation (Name and Address, where the animals are proposed to be rehabilitated) : c. Describe method of Euthanasia (If required in the protocol) : d. Method of carcass disposal after euthanasia. : 13. Describe animal transportation methods if extra-institutional transport is envisaged. 14. Use of hazardous agents (use of recombinant DNA-based agents or potential human pathogens requires documented approval of the Institutional Biosafety Committee (IBC). For each category, the agents and the biosafety level required, appropriate therapeutic measures and the mode of disposal of contaminated food, animal wastes and carcasses must be identified). If, your project involved use of any of the below mentioned agent, attach copy of the approval certificates of the respective agencies: (a) Radionucleotides (AERB) (b) Microorganisms / Biological infectious Agents (IBSC) (c) Recombinant DNA (RCGM) (d) Any other Hazardous Chemical / Drugs
  • 6. 6 Investigator’s declaration. 1. I certify that the research proposal submitted is not unnecessarily duplicative of previously reported research. 2. I certify that, I am qualified and have experience in the experimentation on animals. 3. For procedures listed under item 10, I certify that I have reviewed the pertinent scientific literature and have found no valid alternative to any procedure described herein which may cause less pain or distress. 4. I will obtain approval from the IAEC/ CPCSEA before initiating any changes in this study. 5. I certify that performance of experiment will be initiated only upon review and approval of scientific intent by appropriate expert body (Institutional Scientific Advisory Committee / funding agency / other body). 6. I certify that I will submit appropriate certification of review and concurrence for studies mentioned in point 14. 7. I shall maintain all the records as per format (Form D) and submit to Institutional Animal Ethics Committee (IAEC). 8. I certify that, I will not initiate the study before approval from IAEC/ CPCSEA received in writing. Further, I certify that I will follow the recommendations of IAEC/ CPCSEA. 9. I certify that I will ensure the rehabilitation policies are adopted (wherever required). Signature Name ofInvestigator Date:
  • 7. 7 Certificate This is to certify that the project proposal no ........................................entitled ……………………… submitted by Dr./ Mr. / Ms. ……………………………….. has been approved/recommended by the IAEC of……………(Organization) in its meeting held on…………. (date) and ………………(Number and Species of animals) have been sanctioned under this proposal for a duration of next …………………….. months. Authorized by Name Signature Date Chairman: ……………………. ……………… ……………….. Member Secretary: ……………………. ……………… ……………….. Main Nominee of CPCSEA: ……………………. ……………… ……………….. (Kindly make sure that minutes of the meeting duly signed by all the participants are maintained by Office)